Berliner Schlaganfallregister - Nachbefragung Von Patienten Mit Schlaganfall
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.
研究概览
简要总结
The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.
详细描述
Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all patients eligible
排除标准
- 未提供
结局指标
主要结局
Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.
时间窗: September 2010
次要结局
- Compliance/adherence with discharge medication Activities of daily living(September 2010)
- Re-events(September 2010)
- Degree of Disability(September 2010)
- Mortality(September 2010)
